IRIS
BONADONNA, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.012
AS - Asia 6.615
EU - Europa 4.973
SA - Sud America 1.101
AF - Africa 300
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 9
Totale 21.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.814
SG - Singapore 2.910
CN - Cina 1.996
SE - Svezia 981
IE - Irlanda 967
BR - Brasile 894
IT - Italia 724
HK - Hong Kong 590
UA - Ucraina 524
DE - Germania 414
VN - Vietnam 408
FI - Finlandia 357
TR - Turchia 307
NL - Olanda 287
GB - Regno Unito 267
ZA - Sudafrica 211
RU - Federazione Russa 153
CA - Canada 140
AR - Argentina 81
IN - India 75
BD - Bangladesh 51
FR - Francia 50
AT - Austria 46
IQ - Iraq 46
ES - Italia 37
ID - Indonesia 36
EC - Ecuador 35
MX - Messico 33
JP - Giappone 32
CZ - Repubblica Ceca 30
PL - Polonia 28
MA - Marocco 25
BE - Belgio 22
VE - Venezuela 22
LT - Lituania 21
UZ - Uzbekistan 21
CO - Colombia 19
IR - Iran 18
PK - Pakistan 18
CI - Costa d'Avorio 17
KR - Corea 17
EU - Europa 15
RO - Romania 15
UY - Uruguay 14
PE - Perù 12
JO - Giordania 11
KE - Kenya 10
PY - Paraguay 10
MY - Malesia 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
PT - Portogallo 8
AZ - Azerbaigian 7
IL - Israele 7
AU - Australia 6
BG - Bulgaria 6
BO - Bolivia 6
DK - Danimarca 6
OM - Oman 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
HN - Honduras 5
LB - Libano 5
NG - Nigeria 5
PH - Filippine 5
RS - Serbia 5
EG - Egitto 4
KG - Kirghizistan 4
KZ - Kazakistan 4
CR - Costa Rica 3
DZ - Algeria 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
ME - Montenegro 3
NP - Nepal 3
SA - Arabia Saudita 3
TH - Thailandia 3
AL - Albania 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
CM - Camerun 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
IM - Isola di Man 2
LV - Lettonia 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
CD - Congo 1
Totale 20.999
Salva come PNG Salva come JPEG
Città #
Singapore 1.397
Chandler 1.077
Dublin 958
Dallas 784
Ashburn 731
Beijing 634
Hong Kong 579
Jacksonville 497
Boardman 421
Santa Clara 380
Ann Arbor 360
Parma 278
Izmir 265
Nanjing 233
Princeton 218
Johannesburg 202
New York 164
Dearborn 157
Wilmington 156
Ho Chi Minh City 153
Los Angeles 138
Columbus 115
San Mateo 114
Moscow 111
Shanghai 110
The Dalles 110
Hanoi 95
Munich 91
Toronto 84
São Paulo 79
Hefei 74
Buffalo 73
Kunming 70
Nanchang 68
Woodbridge 63
Shenyang 55
Hebei 49
Helsinki 49
Milan 44
Guangzhou 43
Council Bluffs 42
Jiaxing 41
Seattle 41
Jinan 38
Changsha 35
Tianjin 33
Vienna 33
Des Moines 31
Houston 28
Turku 28
Chicago 27
Jakarta 27
Rio de Janeiro 27
Brooklyn 26
Falls Church 26
Frankfurt am Main 26
Tokyo 25
Bremen 24
London 24
Phoenix 24
Brussels 22
Curitiba 22
Montreal 22
Norwalk 21
Atlanta 20
Bologna 20
Warsaw 19
Zhengzhou 19
Nuremberg 18
Abidjan 17
Baghdad 17
Belo Horizonte 17
Porto Alegre 17
Tashkent 17
Brno 16
Dong Ket 16
Hangzhou 16
Rome 16
San Jose 16
Seoul 16
Amsterdam 15
Chennai 15
Da Nang 15
Piacenza 15
Boston 14
Brasília 14
Istanbul 14
Pune 14
Stockholm 14
Grafing 13
Mestre 13
Chengdu 12
Denver 12
Fremont 12
Hải Dương 12
Iğdır 12
Montevideo 12
Salvador 12
San Francisco 12
Biên Hòa 11
Totale 12.512
Salva come PNG Salva come JPEG
Nome #
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations 223
Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project 201
Chronic consumption of a bergamot-based beverage does not affect glucose, lipid and inflammatory biomarkers of cardiometabolic risk in healthy subjects: a randomised controlled intervention study 192
Claimed effects, outcome variables and methods of measurement for health claims proposed under European community regulation 1924/2006 in the framework of maintenance of skin function 181
Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health 181
Absorption, Pharmacokinetics, and Urinary Excretion of Pyridines After Consumption of Coffee and Cocoa-Based Products Containing Coffee in a Repeated Dose, Crossover Human Intervention Study 179
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management 179
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: Potential relevance to prevention of cardiovascular events 177
Metabolomic Changes after Coffee Consumption: New Paths on the Block 177
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health. 173
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health 167
Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells 160
Pasta Structure Affects Mastication, Bolus Properties, and Postprandial Glucose and Insulin Metabolism in Healthy Adults 160
Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006 157
Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells 154
Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects(PLoS ONE (2018)12:8(e0182559) DOI: 10.1371/journal.pone.0182559) 147
Development and validation of an analytical hplc method to assess chemical and radiochemical purity of [68ga]ga-nodaga-exendin-4 produced by a fully automated method 146
Effect of coffee and cocoa-based confectionery containing coffee on markers of dna damage and lipid peroxidation products: Results from a human intervention study 145
Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: From the ALTER-BIO (alternative cardiovascular bio-imaging markers) registry 144
Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. 142
Adipocytes IGFBP-2 expression in prepubertal obese children. 142
Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006 141
Beta-cell function across the spectrum of glucose tolerance in obese youth. 136
A compartmental model to quantitate in vivo glucose transport in the human forearm 136
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. 135
Effect of different patterns of consumption of coffee and a cocoa-based product containing coffee on the nutrikinetics and urinary excretion of phenolic compounds 134
Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells 132
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 131
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria 130
Transcriptomic analysis of human polarized macrophages: More than one role of alternative activation? 129
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. 127
A performance score of the quality of inpatient diabetes care is a marker of clinical outcomes and suggests a cause-effect relationship between hypoglycaemia and the risk of in-hospital mortality 127
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects 126
Bicarbonate kinetics in humans: identification and validation of athree-compartment model 125
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 125
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 124
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 123
Pathogenesis of NIDDM. A balanced overview. 122
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study 122
Associations Between Pancreatic Lipids and β-Cell Function in Black African and White European Men With Type 2 Diabetes 120
Bariatric surgery or medical therapy for obesity 119
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations 117
Operation of Randle's cycle in patients with NIDDM 116
Claimed effects, outcome variables and methods of measurement for health claims proposed under regulation (EC) 1924/2006 and related to cognitive function in adults 114
Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics 113
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. 112
Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects 112
Total body fat content and fat topography are differently associated with in vivo glucose metabolism in nonobese and obese women. 111
Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: A 12-month randomized controlled trial in patients with type 2 diabetes 111
Predictors of insulin sensitivity in type 2 diabetes mellitus 110
Which is the eligible patient to be treated with pioglitazone? The expert view. 108
Obesity and insulin resistance in man. A dose response study 108
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in nondiabetic subjects. The GISIR database. 108
Influence of cell age and keto-aminic linkage on rapid glycosylation of hemoglobin in human red cell in vitro 107
SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders 107
Intracellular glucose metabolism and insulin resistance in obese non-insulin dependent diabetes. Compensatory effects of hyperglycemia and hyperinsulinemia. 106
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: The Bruneck study 106
Treatment intensification in patients with inadequate glycemic control on basal insulin: Rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists 106
Evaluating endothelial function of the common carotid artery: An in vivo human model. 106
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 106
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 105
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 103
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 102
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. 101
Stearic acid at physiologic concentrations induces in vitro lipotoxicity in circulating angiogenic cells 101
A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy 101
Phasic insulin release and metabolic regulation in type 2 diabetes 100
Estimation of organ transport function for recirculating indicator dilution curves 100
Removal of catheter distortion in multiple indicator dilution studies: a deconvolution-based method and case studies on glucose blood-tissue exchange 100
Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19 99
Fasting plasma glucose variability predicts 10-year survival of Type 2 diabetic patients. The Verona Diabetes Study 99
Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? 99
Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women 98
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes. 98
Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. 98
Time dependence of the interaction between lipid and glucose in humans 97
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 97
Metabolic and hemodynamic effects of insulin on human hearts 97
The metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. 97
Association of a 62 Variants Type 2 Diabetes Genetic Risk Score with Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study 96
Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus 95
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 95
Metabolic interactions of amino acids and glucose in healthy humans 95
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial 94
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance 94
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 94
Protein metabolism in human obesity: Relationship with glucose and lipid metabolism and with visceral adipose tissue. 94
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy 94
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health 93
Effects of glucosamine infusion on insulin secretion and insulin action in humans 93
Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans 92
Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population. 92
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus 92
Muscle glucose transport and phosphorylation in type 2 diabetic, obese non-diabetic, and genetically predisposed individuals. 92
Impaired glucose tolerance, type 2 diabetes mellitus and carotid atherosclerosis. Prospective results from the Bruneck Study 91
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 91
Plasma glucose within the normal range is not associated with carotid atherosclerosis. Prospective results in subjects with normal glucose tolerance from the Bruneck Study 90
Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle 89
Relationship between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals. Role of adipose tissue 89
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes 89
Totale 12.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021926 0 0 0 0 0 150 136 26 226 76 205 107
2021/20221.084 92 38 24 29 47 36 143 128 55 56 18 418
2022/20233.628 357 236 158 299 401 448 23 218 1.297 17 127 47
2023/20241.399 90 136 66 50 113 334 72 96 40 49 146 207
2024/20254.754 79 302 336 311 583 341 127 278 617 503 409 868
2025/20265.493 733 1.097 1.264 661 1.488 250 0 0 0 0 0 0
Totale 21.489